SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 369 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,830,728 | +21.3% | 17,916 | -0.6% | 0.00% | 0.0% |
| Q1 2024 | $2,332,998 | +77.7% | 18,021 | +32.3% | 0.00% | 0.0% |
| Q4 2023 | $1,313,086 | -20.5% | 13,617 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $1,650,652 | -16.3% | 13,617 | -20.9% | 0.00% | 0.0% |
| Q2 2023 | $1,972,034 | +0.3% | 17,220 | +20.7% | 0.00% | 0.0% |
| Q1 2023 | $1,966,144 | +121042.6% | 14,265 | +13.9% | 0.00% | 0.0% |
| Q4 2022 | $1,623 | -99.9% | 12,527 | -49.6% | 0.00% | -50.0% |
| Q3 2022 | $2,746,000 | +27.2% | 24,844 | -13.8% | 0.00% | 0.0% |
| Q2 2022 | $2,159,000 | -12.3% | 28,806 | -8.6% | 0.00% | +100.0% |
| Q1 2022 | $2,461,000 | -13.5% | 31,502 | -0.2% | 0.00% | -50.0% |
| Q4 2021 | $2,844,000 | -2.2% | 31,580 | +0.4% | 0.00% | 0.0% |
| Q3 2021 | $2,908,000 | +33.8% | 31,442 | +12.4% | 0.00% | +100.0% |
| Q2 2021 | $2,174,000 | +2.5% | 27,968 | -1.8% | 0.00% | 0.0% |
| Q1 2021 | $2,122,000 | -55.9% | 28,470 | +0.9% | 0.00% | -75.0% |
| Q4 2020 | $4,808,000 | +5.7% | 28,203 | -12.9% | 0.00% | 0.0% |
| Q3 2020 | $4,547,000 | -21.8% | 32,376 | -10.8% | 0.00% | -33.3% |
| Q2 2020 | $5,818,000 | +45.6% | 36,283 | -11.2% | 0.01% | +20.0% |
| Q1 2020 | $3,997,000 | -9.5% | 40,859 | +19.4% | 0.01% | +25.0% |
| Q4 2019 | $4,417,000 | +62.3% | 34,226 | -5.3% | 0.00% | +33.3% |
| Q3 2019 | $2,722,000 | -49.5% | 36,141 | +2.0% | 0.00% | -50.0% |
| Q2 2019 | $5,386,000 | -4.2% | 35,448 | -28.0% | 0.01% | +50.0% |
| Q1 2019 | $5,623,000 | +109.5% | 49,258 | +100.3% | 0.00% | 0.0% |
| Q4 2018 | $2,684,000 | -32.1% | 24,598 | +0.5% | 0.00% | -20.0% |
| Q3 2018 | $3,951,000 | -9.9% | 24,465 | -26.3% | 0.01% | -16.7% |
| Q2 2018 | $4,387,000 | +50.9% | 33,187 | -15.4% | 0.01% | +50.0% |
| Q1 2018 | $2,907,000 | +22.5% | 39,231 | -8.0% | 0.00% | +33.3% |
| Q4 2017 | $2,373,000 | +22.7% | 42,648 | +0.0% | 0.00% | 0.0% |
| Q3 2017 | $1,934,000 | – | 42,642 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 87,180 | $2,581,000 | 3.60% |
| Perceptive Advisors | 1,771,029 | $52,422,000 | 2.99% |
| SPHERA FUNDS MANAGEMENT LTD. | 483,047 | $14,298,000 | 2.80% |
| HealthCor Management, L.P. | 1,550,000 | $45,880,000 | 2.10% |
| Camber Capital Management LP | 1,350,000 | $39,960,000 | 1.62% |
| Tourbillon Capital Partners, L.P. | 1,537,518 | $45,511,000 | 1.17% |
| Elk Creek Partners, LLC | 562,522 | $16,651,000 | 1.02% |
| EMERALD ADVISERS, LLC | 818,705 | $24,234,000 | 1.00% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 604,467 | $17,892,000 | 0.82% |
| Carlson Capital, L.P. | 1,845,702 | $54,633,000 | 0.70% |